A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Stopped Study withdrawn without starting or enrolling subjects due to a business decision to not proceed with the project.
Conditions
Interventions
- DRUG: Ketotifen/vasoconstrictor
Sponsor
Bausch & Lomb Incorporated